FindTrial
Sign In

Determination of the median effective dose of dexmedetomidine for prevention of emergence agitation in geriatric patients

Determination of the median effective dose of dexmedetomidine for prevention of emergence agitation in geriatric patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023769
Enrollment
Unknown
Registered
2019-06-11
Start date
2019-06-20
Completion date
Unknown
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open surgery

Interventions

Case series:dexmedetomidine

Sponsors

Anqing Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patient who want to accept dexmedetomidine for prevention of emergence agitation ; 2. The patient have no contraindication of bradycardia; 3. Aged >70 years; 4. The patient going to receive open surgery.

Exclusion criteria

Exclusion criteria: 1. The patient who wantn't to accept dexmedetomidine for prevention of emergence agitation; 2. The patient have some contraindications of bradycardia; 3. The patient who have severe hypertation.

Design outcomes

Primary

MeasureTime frame
emergence agitation;—

Countries

China

Contacts

Public ContactWei-Bing Wang

Anqing municipal hospital Anhui province

w2bwang@sina.com+86 13500558021

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026